MedTrace Logo

Cohort Study on People Who Inject Drugs in Senegal

NCT03459768 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 208

Last updated 2021-06-08

No results posted yet for this study

Summary

The main purpose of the CoDISEN cohort study is to propose a model of prevention and care for HIV and viral hepatitis adapted to the needs of people who inject drugs (PWID) in Dakar, Senegal.

Conditions

  • Drug Addiction
  • HIV/AIDS
  • Hepatitis C, Chronic
  • Hepatitis C, Acute
  • Hepatitis B, Chronic
  • Hepatitis B Acute
  • Tuberculosis
  • Sexually Transmitted Diseases
  • Psychiatric Disorder

Sponsors & Collaborators

  • French National Agency for Research on AIDS and Viral Hepatitis

    lead OTHER_GOV

Principal Investigators

  • Pierre-Marie Girard, M.D., PhD · Inserm - Sorbonne Université

  • Moussa Seydi, M.D. · CRCF - CHNU Fann

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-24
Primary Completion
2021-06-30
Completion
2021-06-30

Countries

  • Senegal

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03459768 on ClinicalTrials.gov